89 related articles for article (PubMed ID: 15171452)
1. [Development of combined drugs (ARB and diuretics)].
Arakawa K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():662-5. PubMed ID: 15171452
[No Abstract] [Full Text] [Related]
2. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
3. [Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology].
Winkler G; Jermendy G; Matos L
Orv Hetil; 2003 Sep; 144(36):1763-8. PubMed ID: 14579673
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-II receptor antagonists: their place in therapy.
Kirk JK
Am Fam Physician; 1999 Jun; 59(11):3140-8. PubMed ID: 10392595
[TBL] [Abstract][Full Text] [Related]
5. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
[No Abstract] [Full Text] [Related]
6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?
Grossman E; Messerli FH; Neutel JM
Arch Intern Med; 2000 Jul; 160(13):1905-11. PubMed ID: 10888965
[No Abstract] [Full Text] [Related]
8. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
11. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
14. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
[No Abstract] [Full Text] [Related]
15. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
Ura N; Yamaji I
Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
[No Abstract] [Full Text] [Related]
16. A vaccine for hypertension.
Ménard J
J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
[No Abstract] [Full Text] [Related]
17. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor].
Higashiura K; Shimamoto K
Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698
[No Abstract] [Full Text] [Related]
18. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Demeilliers B; Jover B; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
Boucek P
Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
